Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130271 · ClinicalTrials.gov registry record
PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 42
- Enrollment target
NCT02130271: Completed study, sponsored by Massachusetts General Hospital.
NCT02130271 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02130271 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the spine shows areas of inflammation using a specific type of imaging (pictures).
Interventions
- OTHER Blood draw
- DRUG Radioactive dye
- RADIATION PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02130271
The ClinicalTrials.gov registry entry for NCT02130271 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT02130271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02130271 about?
NCT02130271 is a clinical study titled "PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients". The purpose of this study is to see if the spine shows areas of inflammation using a specific type of imaging (pictures).
What is the current status of trial NCT02130271?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2014-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02130271?
The interventions under investigation include: Blood draw (OTHER), Radioactive dye (DRUG), PET/MRI (RADIATION).
Who is sponsoring clinical trial NCT02130271?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.